Innovating for a Healthier Tomorrow
Welcome to Torrent Pharma, the flagship company of the Torrent Group, a leading pharmaceutical company in India. Established in the early '70s, we have come a long way from being a small generic company to one of the leading pharmaceutical companies in the Country. Our success story is built on the strong foundation of values and ethics laid down by our founder, Late Shri U N Mehta. We are proud to be a significant contributor to the Indian healthcare sector with a turnover of Rs 9620 Cr (FY 2023).
Business Areas
*India*
Torrent Pharma is one of the leading pharmaceutical companies in India with a significant presence in cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), and women healthcare (WHC). We also have a significant presence in diabetology, pain management, gynaecology, oncology, and anti-infective segments. We are ranked first amongst Indian Companies for having the largest market share in Brazil and Germany.
*International*
We have a significant presence in more than 40 countries, and we are all poised to spread our wings across the globe with strong technical capabilities and international accreditations. Our international business is segregated into US, UK, Germany, Europe, Brazil, and Rest of the World.
Products and Therapeutic Areas
We are committed to providing high-quality healthcare solutions through our extensive range of products and therapeutic areas. Our portfolio includes a wide range of products in cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), and women healthcare (WHC) segments. We also have a significant presence in diabetology, pain management, gynaecology, oncology, and anti-infective segments.
Prescribing Information and Report Adverse Event
Our commitment to quality and safety is paramount. We provide prescribing information and report adverse event services to ensure the safe and effective use of our products. Our team of experts is always available to provide guidance and support to healthcare professionals and patients.
Quick Facts
- 7 Manufacturing Plants
- 750+ Scientists
- 2000+ Product Registrations
- Presence in 40+ Countries
News & Events
We are committed to innovation and excellence in everything we do. We regularly announce quarterly results, agreements, product launches, and other news and events to keep our stakeholders informed.
In Conclusion
Torrent Pharma is more than just a healthcare company. We are dedicated to improving the quality of life of people around the world through our high-quality healthcare solutions. We are committed to innovation, excellence, and sustainability in all our activities. We are proud of our heritage, and we are excited about our future. Join us in our journey towards a healthier tomorrow.
Quality and Safety Concerns
Reviews of Torrent Pharma's products have raised significant concerns about the quality and safety of their medications. According to a 2018 FDA report, Torrent Pharma products were found to contain a probable human carcinogen, NDMA, in certain products such as Valsartan/Amlodipine/HCTZ, Valsartan/Amlodipine, and Valsartan tablets. This has led to criticisms about the company's testing and sourcing practices, particularly in regards to materials sourced from China without adequate testing.
Lack of Transparency and Accountability
Several reviewers have expressed outrage and frustration with Torrent Pharma's handling of the situation. One reviewer suggested that the company is more interested in making a profit than in ensuring the safety of its customers. Another reviewer emphasized that the contamination of their products is not an isolated incident, but rather a widespread problem in the pharmaceutical industry.
FDA Warnings and Repercussions
The FDA has issued warnings about the contamination of certain medications, and recalls have been issued for various versions of the affected drugs. Some reviewers have noted that the lack of stricter regulations and oversight in the industry contributes to the problem. One reviewer questioned the safety and purity of "price-oriented" ingredients from China and India.
Be the first to review Torrent Pharmaceuticals.
Write a Review
